134 related articles for article (PubMed ID: 17157603)
1. Age-related macular degeneration is associated with an increased risk of hip fractures in the Medicare database.
Anastasopoulos E; Yu F; Coleman AL
Am J Ophthalmol; 2006 Dec; 142(6):1081-3. PubMed ID: 17157603
[TBL] [Abstract][Full Text] [Related]
2. Incidence of exudative age-related macular degeneration among elderly Americans.
Javitt JC; Zhou Z; Maguire MG; Fine SL; Willke RJ
Ophthalmology; 2003 Aug; 110(8):1534-9. PubMed ID: 12917168
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Smith W; Wang JJ
Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
[TBL] [Abstract][Full Text] [Related]
4. The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec.
Tournier M; Moride Y; Lesk M; Ducruet T; Rochon S
Can J Clin Pharmacol; 2008; 15(1):e22-35. PubMed ID: 18579928
[TBL] [Abstract][Full Text] [Related]
5. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
Wong TY; Tikellis G; Sun C; Klein R; Couper DJ; Sharrett AR
Ophthalmology; 2007 Jan; 114(1):86-91. PubMed ID: 17198851
[TBL] [Abstract][Full Text] [Related]
6. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
Coleman AL; Yu F
Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
[TBL] [Abstract][Full Text] [Related]
7. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.
Alexander SL; Linde-Zwirble WT; Werther W; Depperschmidt EE; Wilson LJ; Palanki R; Saroj N; Butterworth SL; Ianchulev T
Ophthalmology; 2007 Dec; 114(12):2174-8. PubMed ID: 18054636
[TBL] [Abstract][Full Text] [Related]
8. Comparison of comorbid conditions between neovascular age-related macular degeneration patients and a control cohort in the medicare population.
Zlateva GP; Javitt JC; Shah SN; Zhou Z; Murphy JG
Retina; 2007; 27(9):1292-9. PubMed ID: 18046240
[TBL] [Abstract][Full Text] [Related]
9. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
[TBL] [Abstract][Full Text] [Related]
10. Propoxyphene use and risk for hip fractures in older adults.
Kamal-Bahl SJ; Stuart BC; Beers MH
Am J Geriatr Pharmacother; 2006 Sep; 4(3):219-26. PubMed ID: 17062322
[TBL] [Abstract][Full Text] [Related]
11. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study.
Jonasson F; Arnarsson A; Peto T; Sasaki H; Sasaki K; Bird AC
Ophthalmology; 2005 Jan; 112(1):132-8. PubMed ID: 15629833
[TBL] [Abstract][Full Text] [Related]
12. Cataract surgery and the risk of aging macula disorder: the rotterdam study.
Ho L; Boekhoorn SS; Liana ; van Duijn CM; Uitterlinden AG; Hofman A; de Jong PT; Stijnen T; Vingerling JR
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4795-800. PubMed ID: 18599571
[TBL] [Abstract][Full Text] [Related]
13. Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Rochtchina E; Wang JJ
Am J Ophthalmol; 2007 Apr; 143(4):685-7. PubMed ID: 17386278
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study.
Boekhoorn SS; Isaacs A; Uitterlinden AG; van Duijn CM; Hofman A; de Jong PT; Vingerling JR
Ophthalmology; 2008 Nov; 115(11):1899-903. PubMed ID: 18708255
[TBL] [Abstract][Full Text] [Related]
15. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population.
Leveziel N; Souied EH; Richard F; Barbu V; Zourdani A; Morineau G; Zerbib J; Coscas G; Soubrane G; Benlian P
Mol Vis; 2007 Nov; 13():2153-9. PubMed ID: 18079691
[TBL] [Abstract][Full Text] [Related]
16. The use of cholesterol-lowering medications and age-related macular degeneration.
McGwin G; Xie A; Owsley C
Ophthalmology; 2005 Mar; 112(3):488-94. PubMed ID: 15745779
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study.
Rochtchina E; Wang JJ; Flood VM; Mitchell P
Am J Ophthalmol; 2007 Feb; 143(2):344-6. PubMed ID: 17258528
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoking and age-related macular degeneration in the EUREYE Study.
Chakravarthy U; Augood C; Bentham GC; de Jong PT; Rahu M; Seland J; Soubrane G; Tomazzoli L; Topouzis F; Vingerling JR; Vioque J; Young IS; Fletcher AE
Ophthalmology; 2007 Jun; 114(6):1157-63. PubMed ID: 17337063
[TBL] [Abstract][Full Text] [Related]
19. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
Kikuchi M; Nakamura M; Ishikawa K; Suzuki T; Nishihara H; Yamakoshi T; Nishio K; Taki K; Niwa T; Hamajima N; Terasaki H
Ophthalmology; 2007 Sep; 114(9):1722-7. PubMed ID: 17400294
[TBL] [Abstract][Full Text] [Related]
20. Red meat and chicken consumption and its association with age-related macular degeneration.
Chong EW; Simpson JA; Robman LD; Hodge AM; Aung KZ; English DR; Giles GG; Guymer RH
Am J Epidemiol; 2009 Apr; 169(7):867-76. PubMed ID: 19234096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
